Table 2.
Age distribution of patients with EV infection in Gwangju, South Korea, between 2014 and 2020.
| Age | Number of positive/total patients in the age group | Total | |||||
|---|---|---|---|---|---|---|---|
| < 1 years | 1–4 years | 5–9 years | 10–14 years | ≥ 15 years | Unknown | ||
| 2014 | 60/100 | 208/305 | 66/121 | 8/25 | 17/25 | 6/8 | 365/584 |
| 2015 | 70/152 | 237/390 | 98/192 | 16/36 | 2/9 | 7/9 | 430/788 |
| 2016 | 86/169 | 233/336 | 108/281 | 22/53 | 1/8 | 7/14 | 457/861 |
| 2017 | 72/201 | 174/483 | 43/172 | 8/72 | 1/16 | 3/8 | 301/952 |
| 2018 | 67/229 | 226/549 | 59/223 | 13/81 | 1/24 | 4/7 | 370/1113 |
| 2019 | 30/160 | 173/374 | 63/167 | 9/50 | 0/11 | 5/12 | 280/774 |
| 2020 | 7/116 | 6/75 | 3/76 | 1/44 | 0/9 | 0/1 | 17/321 |
| Total (%a) | 392 (17.7) | 1257 (56.6) | 440 (19.8) | 77 (3.5) | 22 (1.0) | 32 (1.4) | 2220/5393 |
aProportion of EV-positive samples from 2014 to 2020.